Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $26.79M | $27.18M | $25.79M | $23.68M |
| Net Income | $7.60M | $6.89M | $8.95M | $8.38M |
| EPS Diluted | $0.53 |
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
| $0.46 |
| $0.59 |
| $0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
